期刊文献+

3-溴丙酮酸对肠癌HCT116细胞的增殖抑制作用及其机制 被引量:2

Inhibitory effect of 3-bromopyruvate on proliferation of colon carcinoma HCT116 cells and its mechanism
下载PDF
导出
摘要 目的:研究3-溴丙酮酸(3-BP)对肠癌细胞HCT116增殖的抑制作用并初步探讨其抑制作用的机制,为3-BP的临床应用提供依据。方法:将体外培养的HCT116细胞分为对照组和不同浓度3-BP组(3-BP的终浓度分别为25、50、75和100mg.L-1)。采用Western blotting法检测己糖激酶Ⅱ(HKⅡ)蛋白表达水平;采用6-磷酸葡萄糖(G-6-P)检测试剂盒检测培养液中G-6-P的浓度;采用MTT比色法测定细胞增殖活性;采用流式细胞术检测细胞周期。结果:与对照组比较,25mg.L-1 3-BP组HKⅡ蛋白表达水平无明显变化(P>0.05),与对照组和25mg.L-1 3-BP组比较,50、75和100 mg.L-1 3-BP组HKⅡ蛋白表达水平均显著下调(P<0.01)。与对照组比较,25 mg.L-1 3-BP组培养液中G-6-P浓度无明显变化(P>0.05);与对照组和25mg.L-1 3-BP组比较,50、75和100mg.L-1 3-BP组培养液中G-6-P的浓度均显著下降(P<0.01)。MTT法,与对照组比较,25mg.L-1 3-BP组细胞存活率无明显变化(P>0.05);与对照组和25mg.L-1 3-BP组比较,50、75和100mg.L-1 3-BP组细胞存活率明显降低(P<0.05)。流式细胞术,与对照组比较,25mg.L-13-BP组G1和S期细胞所占比例无明显变化(P>0.05);与对照组和25 mg.L-1 3-BP组比较,50、75和100mg.L-1 3-BP组S期细胞所占比例逐渐减少(P<0.05),G1期细胞则明显增加(P<0.01),细胞滞留在G1期。结论:3-BP可显著抑制HCT116细胞增殖,其机制可能与3-BP抑制HKⅡ活性、减少细胞对葡萄糖的利用有关。 Objective To study the inhibitory effect of 3-bromopyruvate(3-BP) on proliferation of colon carcinoma HCT116 cells and to explore its mechanism,and to provide evidence for the clinical application of 3-BP.Methods HCT116 cells were cultivated in vitro and divided into control group and different concentrations of 3-BP groups(25,50,75,and 100 mg·L-1).The hexokinaseⅡ(HKⅡ) protein expression levels in various groups were determined by Western blotting method;the concentrations of glucose-6-phosphatase(G-6-P) were determined by G-6-P assay kit;the proliferation activities of the cells were observed by MTT method;the cell cycle was measured by flow cytometry.Results Compared with control group,the HKⅡ protein level in 25 mg·L-1 3-BP group did not change significantly(P0.05);compared with control group and 25 mg·L-1 3-BP group,the HKⅡprotein levels in 50,75,and 100 mg·L-1 3-BP groups were decreased significantly(P0.01).Compared with control group,the concentration of G-6-P in culture medium in 25 mg·L-1 3-BP group did not change significantly(P0.05);compared with control group and 25 mg·L-1 3-BP group,the concentration of G-6-P in culture medium in 50,75,and 100 mg·L-1 3-BP groups were decreased significantly(P0.01).The MTT results showed that compared with control group,the survival rate in 25 mg·L-1 3-BP group did not change significantly(P0.05);compared with control group and 25 mg·L-1 3-BP group,the survival rates in 50,75,and 100 mg·L-1 3-BP groups were decreased markedly(P0.05).The flow cytometry analysis results showed that compared with control group,the percentages of the cells at G1 phase and S phase in 25 mg·L-1 3-BP group did not change significantly(P0.05);compared with control group and 25 mg·L-1 3-BP group,the percentages of the cells at G1 phase in 50,75 and 100 mg·L-1 3-BP groups were increased significantly(P0.01) and the percentages of the cells at S phase were decreased(P0.05).The cell cycle was arrested at G1 stage.Conclusion 3-BP could inhibit the proliferation of HCT116 cells significantly,which may be related to the decreasing of HKⅡ protein expression and use of glucose.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2013年第3期525-528,I0002,共5页 Journal of Jilin University:Medicine Edition
基金 辽宁省教育厅重点实验室项目资助课题(LS2010101)
关键词 3-溴丙酮酸 HCT116 己糖激酶Ⅱ 6-磷酸葡萄糖 3-bromopyruvate HCT116 hexokinaseⅡ glucose-6-phosphate
  • 相关文献

参考文献13

  • 1De Berardinis RJ,Lum JJ,Hatzivassiliou G,et al.Thebiology of cancer:metabolic reprogramming fuels cell growthand proliferation[J].Cell Metab,2008,7(1):11-20.
  • 2van der Heiden MG,Cantley LC,Thompson CB.Understanding the Warburg effect:the metabolic requirementsof cell proliferation[J].Science,2009,324(5930):1029-1033.
  • 3Mathupala SP,Ko YH,Pedersen PL.Hexokinase II:cancer’s double-edged sword acting as both facilitator andgatekeeper of malignancy when bound to mitochondria[J] Oncogene,2006,25(34):4777-4786.
  • 4Fonteyne P,Casneuf V,Pauwels P,et al.Expression ofhexokinases and glucose transporters in treated and untreatedoesophageal adenocarcinoma[J].Histol Histopathol,2009,24(8):971-977.
  • 5Peter L.Pedersen.3-Bromopyruvate(3BP)a fast acting,promising,powerful,specific,and effective“small molecule”anti-cancer agent taken from labside to bedside:introduction toa special issue[J].J Bioenerg Biomembr,2012,44(1):1-6.
  • 6Jean-Francois H,Geschwind,Young H,et al.Novel therapy forliver cancer:direct intraarterial injection of apotent inhibitor of ATPproduction[J].Cancer Res,2002,62(14):3909-3913.
  • 7Zhao C,Zhang H,Lu WQ,et al.Role of mitochondria-associated hexokinaseⅡin cancer cell death induced by 3-bromopyruvate[J].Biochim Biophys Acta,2009,1787(5):553-560.
  • 8Gwak GY,Yoon JH,Kim KM,et al.Hypoxia stimulatesproliferation of human hepatoma cells through the induction of hexokinase expression[J].Hepatology,2005,42(3):358-364.
  • 9Pedersen PL,Mathupala S,Rempel A,et al.Mitochondrialbound typeⅡhexokinase:a key player in the growth andsurvival of many cancers and ideal prospect for therapeuticintervention[J].Biochim Biophys Acta,2002,1555(1-3):14-20.
  • 10Robey RB,Hay N.Mitochondrial hexokinases:guardians ofthe mitochondria[J].Cell Cycle,2005,4(5):654-658.

同被引文献15

  • 1邱成志,王川,吴友谊,朱世泽,张祥福.结直肠癌组织中Survivin表达与细胞增殖的关系[J].中国癌症杂志,2004,14(5):425-428. 被引量:2
  • 2彭秋平,梁后杰,周琪,周进明,傅晓岚,钟大平.己糖激酶-Ⅱ基因在人结肠癌细胞中的表达及其治疗意义[J].中华医学杂志,2007,87(15):1058-1062. 被引量:12
  • 3Garber K. Energy deregulation : licensing tumors to grow [ J ]. Science, 2006, 312(5777): 1158.
  • 4Pedersen P L. Warburg, me and Hexokinase 2: Multiple dis- coveries of key molecular events underlying one of cancers'most common phenotypes, the "Warburg Effect", ie, elevated gly- eolysis in the presence of oxygen [ J]. J Bioenerg Biomembr, 2007, 39(3) : 211.
  • 5Pedersen P L. The cancer cell's "power plants" as promising therapeutic targets: an overview [ J]. J Bioenerg Biomembr, 2007, 39(1): 1.
  • 6Pedersen P L, Mathupala S, Rempel A, et al. Mitochondrial bound type Ⅱ hexokinase: a key player in the growth and sur- vival of many cancers and an ideal prospect for therapeutic in- tervention [ J ]. Biochim Biophys Acta, 2002, 1555 ( 1/3 ) : 14.
  • 7Peng Q, Zhnn Q, Zhou J, et ah Stable RNA interference of hexnkinase Ⅱ gene inhibits human colon cancer LaVa eell growth invitroand in viva [ J ]. Cancer Biol Ther, 2008, 7 (7) : 1128.
  • 8Wang F, Ogasawara M A, Huang P. Small mitochondfia-tar- geting molecules as anti-cancer agents [ J ]. Molecular aspects of medicine, 2010, 31 ( 1 ) : 75.
  • 9Penso J, Beitner R. Lithium detaches hexokinase from mito- ehondria and inhibits proliferation of B16 melanoma cells[ J]. Mol Genet Metab, 2003, 78 ( 1 ) : 74.
  • 10汪忠煜,杨明炜,陈立,刘艳娟,陆付耳,黄光英.小檗碱与梓醇及其配伍对胰岛素抵抗3T3-L1脂肪细胞Glut-4、IRS-1、IRS-1 Ser307磷酸化蛋白表达的影响[J].中国药师,2008,11(10):1142-1145. 被引量:13

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部